Repare Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Repare Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Repare Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6.52M, a 4.05% increase year-over-year.
  • Repare Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $25.7M, a 14.3% increase year-over-year.
  • Repare Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25.1M, a 27.3% increase from 2022.
  • Repare Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.7M, a 53.5% increase from 2021.
  • Repare Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.8M, a 406% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $25.1M +$5.37M +27.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $19.7M +$6.86M +53.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $12.8M +$10.3M +406% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $2.54M +$2.03M +396% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $511K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.